Issue 4/2021
Content (20 Articles)
Device-based treatment options for heart failure with preserved ejection fraction
Chihiro Miyagi, Takuma Miyamoto, Jamshid H. Karimov, Randall C. Starling, Kiyotaka Fukamachi
Wearable cardioverter defibrillator: bridging for implantable defibrillators in left ventricular assist device patients
Filippos-Paschalis Rorris, Christos Charitos
High-density lipoprotein-mediated cardioprotection in heart failure
Ampadu O. Jackson, Jun Meng, Huifang Tang, Kai Yin
Etiologies and predictors of readmission among obese and morbidly obese patients admitted with heart failure
Pradhum Ram, Mahek Shah, Kevin Bryan U Lo, Manyoo Agarwal, Brijesh Patel, Byomesh Tripathi, Shilpkumar Arora, Nilay Patel, Ulrich P Jorde, Sourin Banerji
Cardiac 1H MR spectroscopy: development of the past five decades and future perspectives
Ashish Gupta, Brian Houston
Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis
Vasiliki Bistola, John Parissis, Emmanouil Foukarakis, Pipitsa N. Valsamaki, Aris Anastasakis, Georgios Koutsis, Georgios Efthimiadis, Efstathios Kastritis
Oxidative stress and inflammation: determinants of anthracycline cardiotoxicity and possible therapeutic targets
Iacopo Fabiani, Alberto Aimo, Chrysanthos Grigoratos, Vincenzo Castiglione, Francesco Gentile, Luigi F Saccaro, Chiara Arzilli, Daniela Cardinale, Claudio Passino, Michele Emdin
Management of RAASi-associated hyperkalemia in patients with cardiovascular disease
José Silva-Cardoso, Dulce Brito, João Miguel Frazão, Aníbal Ferreira, Paulo Bettencourt, Patrícia Branco, Cândida Fonseca
Balloon pulmonary angioplasty vs. pulmonary endarterectomy in patients with chronic thromboembolic pulmonary hypertension: a systematic review and meta-analysis
Liyan Zhang, Yuping Bai, Peijing Yan, Tingting He, Bin Liu, Shanlian Wu, Zhen Qian, Changtian Li, Yunshan Cao, Min Zhang
Cardiotoxicity in HER2-positive breast cancer patients
Diana Gonciar, Lucian Mocan, Alexandru Zlibut, Teodora Mocan, Lucia Agoston-Coldea
Obstructive sleep apnea and cardiac mechanics: how strain could help us?
Marijana Tadic, Cesare Cuspidi, Guido Grassi, Giuseppe Mancia
Sodium-glucose co-transporter 2 inhibitors and heart failure—the present and the future
Melanie Nana, Holly Morgan, L. N. Rao Bondugulapati
The soluble catalytic ectodomain of ACE2 a biomarker of cardiac remodelling: new insights for heart failure and COVID19
Artemio García-Escobar, Santiago Jiménez-Valero, Guillermo Galeote, Alfonso Jurado-Román, Julio García-Rodríguez, Raúl Moreno
Screening, detection, and management of heart failure in the SARS-CoV2 (COVID-19) pandemic
Alberto Palazzuoli, Gaetano Ruocco, Kristen M. Tecson, Peter A. McCullough
The role of mechanotransduction in heart failure pathobiology—a concise review
Wolfgang Krueger, Nicole Bender, Martin Haeusler, Maciej Henneberg
A meta-analysis of microRNA expression profiling studies in heart failure
Alieh Gholaminejad, Nasrin Zare, Nasim Dana, Davood Shafie, Arya Mani, Shaghayegh Haghjooy Javanmard